Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-03-04

Clinical Trial Update: Efficacy of Pimozide Augmentation for Clozapine Partial Response [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating whether adding pimozide to clozapine improves outcomes in schizophrenia patients with partial response. The results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Clozapine (Clozapine)
  • Pimozide (Pimozide)

Snippet

Sponsor: Yale University | Conditions: Schizophrenia | Phase 2 | Status: COMPLETED | Results posted: 2016-03-04